MONOPAR THERAPEUTICS INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.618 USD | +3.33% |
|
-13.68% | +80.42% |
| 05-09 | Monopar Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-16 | Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 0.7920 | 1.350 | 1.300 |
| Spread/Res. | -22.50% | -54.53% | -52.78% |
| Spread/Supp. | +3.93% | +112.17% | +104.53% |
| Support | 0.5906 | 0.2893 | 0.3001 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- MNPR Stock
- Charts Monopar Therapeutics Inc.
